Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • FEATURED
  • Does the neutrophil level detect the severity of COVID-19?

Novozymes Research Associate Job | Life Sciences | Apply Online

COVID-19 or DENGUE?

Does the neutrophil level detect the severity of COVID-19?
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

Does the neutrophil level detect the severity of COVID-19?

bioxone September 9, 2020September 9, 2020

–Sanket Roy, Team bioXone

Hyperactivation of the immune system under SARS-CoV-2 infection is one of the most important features of COVID-19. While the early detection of COVID- 19 became the most emerging field of research, a team of scientists led by Hyung Chun of Yale University has identified that detection of neutrophil levels in plasma can indicate the severity of the disease in patients.

Neutrophils are one among the fighter cells in innate immunity that show a prompt response to any kind of infection but also cause damage to uninfected tissues. The study was done via the detection of protein levels in the blood plasma using machine learning. A study among 3300 COVID 19 patients was conducted. A number of patients among them who developed a more severe form of the disease were previously diagnosed with higher levels of neutrophil associated proteins in the plasma than the ones who did not escalate to the severe stage of the disease.  It also has been found that patients with high neutrophil levels show a high mortality rate.  

Source- A neutrophil activation signature predicts critical illness and mortality in COVID-19, doi: https://doi.org/10.1101/2020.09.01.20183897

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Covid detection neutrophil

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID-19 or DENGUE?

bioxone September 10, 2020

–Arpita  Adhikary, Amity University Kolkata When the 21st century is facing pandemic, it is reported that Dengue and coronavirus share almost similar clinical features that cannot be discriminated. There are few independent research studies that observed false-positive tests for coronavirus. In Singapore, two false-positive results from rapid serological testing for dengue was later confirmed to […]

Related Post

  • BiotechToday
  • India
  • World

Covid Update: Moderna Vaccine on the Horizon!

bioxone October 20, 2020October 20, 2020

Chitra Roy, University of Calcutta An American biotechnology company ‘Moderna’, based in Cambridge, Massachusetts focuses on the discovery and development of drugs in addition to vaccine technologies. They exclusively use messenger RNA (mRNA) therapeutics and designs vaccines to create a completely new generation of transformative medicines. Against COVID-19, Moderna has developed its mRNA vaccine candidate […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Newly discovered salivary glands aid advanced radiation therapies

bioxone October 23, 2020October 23, 2020

Jayateerth S. Bhavikatti, CSIR-National Chemical Laboratory, Pune, India There have been so many things discovered till date in this universe, nevertheless, there are too many discoveries to happen. Cheers to the discoverers! They spend their life helping people. Here is one such discovery. So far, three pairs of salivary glands were studied in humans. Researches […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ENGINEERED ONCOLYTIC ADENOVIRUS TO TREAT METASTATIC CANCER

bioxone December 2, 2020December 2, 2020

Husna, Amity University Kolkata Oncolytic viruses are genetically engineered for the destruction of cancer or tumour-causing cells specifically. They’re delivered for treatment inside the body via intravenous injection. In 2015, one such oncolytic virus was approved by the FDA for treating skin cancer, melanoma. A major obstacle in the application of oncolytic adenoviruses is that […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy